University of Florida-Health Cancer Center-Orlando ( Site 0015) — Orlando, Florida

University of Florida-Health Cancer Center-Orlando ( Site 0015) is a clinical research site located in Orlando, Florida, United States 32806.

Crixeo Clinical Trials Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Florida-Health Cancer Center-Orlando ( Site 0015) has participated in 1 clinical trials.

Therapeutic areas: Advanced Solid Tumors, Triple Negative Breast Cancer, Ovarian Cancer.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Orlando

Browse all research sites in Florida · View every site in Orlando

Sponsor Feasibility Report

Trust Score: 87/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Florida-Health Cancer Center-Orlando ( Site 0015)?

University of Florida-Health Cancer Center-Orlando ( Site 0015) has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Florida-Health Cancer Center-Orlando ( Site 0015) conducted?

University of Florida-Health Cancer Center-Orlando ( Site 0015) has 1 clinical trials on record. Their work covers Advanced Solid Tumors, Triple Negative Breast Cancer, Ovarian Cancer.

Is University of Florida-Health Cancer Center-Orlando ( Site 0015) accredited by Crixeo Clinical Trials?

University of Florida-Health Cancer Center-Orlando ( Site 0015) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Florida-Health Cancer Center-Orlando ( Site 0015)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.